Early treatment with inhibitors of P2Y12 receptor in patients with ST-segment elevation myocardial infarction - 2023 ESC recommendations and scientific evidence. Is clinical evidence sufficient to suggest a move towards precision medicine? The ELECTRA-SIRIO 2 investigators' viewpoint.

Kubica J, Adamski P, Badariene J, Bonaca M, Buszman P, Gabulova R, Gajda R, Geisler T, Gil R, Gorog DA, Gurbel PA, Hajdukiewicz T, Hudzik B, James S, Jeong YH, Kern A, Kochman W, Kubica A, Kuliczkowski W, Magielski P, Niezgoda P, Ostrowska M, Raggi P, Rahimov U, Skonieczny G, Siller-Matula JM, Specchia G, Szarpak Ł, Szymański P, Tantry U, Umińska J, Navarese EP.

Open source

DOI: 10.5603/cj.99973
Published: 2025-03-20
Container: Cardiol J
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.5603/cj.99973,
  title = {Early treatment with inhibitors of P2Y12 receptor in patients with ST-segment elevation myocardial infarction - 2023 ESC recommendations and scientific evidence. Is clinical evidence sufficient to suggest a move towards precision medicine? The ELECTRA-SIRIO 2 investigators' viewpoint.},
  author = {Kubica J and  Adamski P and  Badariene J and  Bonaca M and  Buszman P and  Gabulova R and  Gajda R and  Geisler T and  Gil R and  Gorog DA and  Gurbel PA and  Hajdukiewicz T and  Hudzik B and  James S and  Jeong YH and  Kern A and  Kochman W and  Kubica A and  Kuliczkowski W and  Magielski P and  Niezgoda P and  Ostrowska M and  Raggi P and  Rahimov U and  Skonieczny G and  Siller-Matula JM and  Specchia G and  Szarpak Ł and  Szymański P and  Tantry U and  Umińska J and  Navarese EP.},
  year = {2025},
  journal = {Cardiol J},
  doi = {10.5603/cj.99973},
  url = {https://doi.org/10.5603/cj.99973}
}

RIS

TY  - JOUR
TI  - Early treatment with inhibitors of P2Y12 receptor in patients with ST-segment elevation myocardial infarction - 2023 ESC recommendations and scientific evidence. Is clinical evidence sufficient to suggest a move towards precision medicine? The ELECTRA-SIRIO 2 investigators' viewpoint.
AU  - Kubica J
AU  -  Adamski P
AU  -  Badariene J
AU  -  Bonaca M
AU  -  Buszman P
AU  -  Gabulova R
AU  -  Gajda R
AU  -  Geisler T
AU  -  Gil R
AU  -  Gorog DA
AU  -  Gurbel PA
AU  -  Hajdukiewicz T
AU  -  Hudzik B
AU  -  James S
AU  -  Jeong YH
AU  -  Kern A
AU  -  Kochman W
AU  -  Kubica A
AU  -  Kuliczkowski W
AU  -  Magielski P
AU  -  Niezgoda P
AU  -  Ostrowska M
AU  -  Raggi P
AU  -  Rahimov U
AU  -  Skonieczny G
AU  -  Siller-Matula JM
AU  -  Specchia G
AU  -  Szarpak Ł
AU  -  Szymański P
AU  -  Tantry U
AU  -  Umińska J
AU  -  Navarese EP.
PY  - 2025
JO  - Cardiol J
DO  - 10.5603/cj.99973
UR  - https://doi.org/10.5603/cj.99973
ER  -

APA

J, K., P, A., J, B., M, B., P, B., R, G., R, G., T, G., R, G., DA, G., PA, G., T, H., B, H., S, J., YH, J., A, K., W, K., A, K., W, K., P, M., P, N., M, O., P, R., U, R., G, S., JM, S., G, S., Ł, S., P, S., U, T., J, U., & EP., N. (2025). Early treatment with inhibitors of P2Y12 receptor in patients with ST-segment elevation myocardial infarction - 2023 ESC recommendations and scientific evidence. Is clinical evidence sufficient to suggest a move towards precision medicine? The ELECTRA-SIRIO 2 investigators' viewpoint.. Cardiol J. https://doi.org/10.5603/cj.99973

Source records

europe-pmc · retrieved 2026-09-26T22:01:40.264Z
doaj · retrieved 2026-09-26T22:01:40.254Z